Our projects are the cornerstone of our institute, each one crucial to our goal of pioneering discoveries in cancer and aging research. Here, you’ll discover a range of initiatives that challenge the limits of scientific knowledge, offering profound insights into the intricate processes that underpin disease and aging. Spearheaded by eminent researchers, our projects encompass molecular biology, genetics, and cellular studies to forge advancements that promise to revolutionise healthcare. Dive into our portfolio of projects below, where we tirelessly work to unravel the secrets of longevity and cellular health.
Currently Running Projects in IRCAN
-
Duration: 2023 – 2026 Funding agency: Nice University Hospital Interferon Alfa Therapy Based on Th17 Profile in Membranous Nephropathy. Interferon Alfa therapy offers a promising…
-
Duration: 2022 – 2024 Funding agency: Nice University Hospital, French Rare Disease ORKID Network Membranous nephropathy (MN) is a kidney disorder that can lead to…
-
Duration: 2020 – ongoing Funding agency: CD06 In response to the unprecedented global pandemic, our team has launched an in-depth study to analyze the immune…
-
Duration: 2020 – 2025 Funding agency: National Clinical Research Program (PHRC 2017) Personalized Medicine in Membranous Nephropathy: Epitope spreading in MN patients, consisting of the…
-
Duration: 2018 – ongoing Funding agency: CD06, GIRCI Méditerranée Immunopathological Analysis of a French cohort of Membranous Nephropathy: Identifying the environmental factors associated with the…
-
Duration: 2022-2024 Funding body: INCa Cancer is a disease often linked to aging, with most cases occurring in older individuals. However, cancer therapies are typically…
-
Duration: 2022-2024 Funding body: ANR This project, led by Dr. Miguel Godinho Ferreira (IRCAN) and in partnership with Pr Philippe Valet from the newly created unit…
-
Duration: 2024 Funding body: La Ligue Contre le Cancer (LNCC) Age is widely recognised as a major factor in the development of cancer. This is…
-
Duration: 2021-2026 Funding body: INSERM The InterAging project, initiated by Inserm, aims to enhance research into aging through international collaboration. Launched in October 2021, this…
-
Duration: 2022-2026 Funding body: ANR The role of p16High immune subsets in the regulation of acute tissue damage as well as their role in aging.…